Related Experiment Video
Updated: Jun 25, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
[A 36-year old female patient presenting with hypoglycemic coma]
M Bala1, T Brünnler, V Guralnik
1Klinik und Poliklinik für Innere Medizin I, Universität Regensburg, Regensburg.
Der Internist
|February 13, 2009
Summary
Sheehan syndrome, a rare condition causing hypopituitarism, can manifest as hypoglycemic shock even after uncomplicated pregnancies. This endocrine disorder results in adrenocorticotropic insufficiency, impacting glucose regulation.
Area of Science:
- Endocrinology
- Reproductive Medicine
Background:
- Sheehan syndrome is a rare but serious condition characterized by pituitary gland necrosis following postpartum hemorrhage.
- It often leads to deficiencies in multiple pituitary hormones, causing a range of endocrine disorders.
Observation:
- A 36-year-old female presented with unexplained hypoglycemic shock.
- Initial investigations ruled out common causes of hypoglycemia, including diabetes mellitus and insulinoma.
- The patient's history revealed a failure to lactate after an uncomplicated pregnancy three years prior.
Findings:
- Endocrinological evaluation confirmed complete adrenocorticotropic insufficiency due to Sheehan syndrome.
- Magnetic resonance imaging (MRI) also revealed an empty sella syndrome.
- These findings indicate that Sheehan syndrome can present with severe hypoglycemia due to hypopituitarism and resulting adrenocorticotropic axis insufficiency.
Implications:
- This case highlights that Sheehan syndrome, even with a history of uncomplicated delivery and normal initial lab values, can manifest later with life-threatening hypoglycemia.
- Early recognition and diagnosis of Sheehan syndrome are crucial for managing hypopituitarism and preventing severe metabolic complications.
- The association with empty sella syndrome warrants further investigation into potential shared etiologies or diagnostic markers.
Related Concept Videos
Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
SBAR II: Application of SBAR
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
